These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2046273

  • 1. Pharmacological and dietary treatment of lipid abnormalities in nephrotic patients.
    D'Amico G, Gentile MG.
    Kidney Int Suppl; 1991 Apr; 31():S65-9. PubMed ID: 2046273
    [No Abstract] [Full Text] [Related]

  • 2. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1991 Jan 11; 33(835):1-4. PubMed ID: 1984601
    [No Abstract] [Full Text] [Related]

  • 3. Reducing cardiac deaths with hypolipidemic drugs.
    Naito HK.
    Postgrad Med; 1987 Nov 01; 82(6):102-12. PubMed ID: 3313343
    [No Abstract] [Full Text] [Related]

  • 4. Drug treatment of hyperlipidemia.
    Samuel P.
    Am Heart J; 1980 Oct 01; 100(4):573-7. PubMed ID: 7415943
    [No Abstract] [Full Text] [Related]

  • 5. Hypolipidemic drugs.
    Fleischmajer R.
    Am Fam Physician; 1978 Feb 01; 17(2):188-90. PubMed ID: 622945
    [No Abstract] [Full Text] [Related]

  • 6. Fenofibrate, probucol, and other lipid-lowering treatments in heart transplant recipients.
    de Lorgeril M, Boissonnat P, Salen P, Monjaud I, Dureau G.
    J Heart Lung Transplant; 1996 May 01; 15(5):539-40. PubMed ID: 8771511
    [No Abstract] [Full Text] [Related]

  • 7. Contemporary recommendations for evaluating and treating hyperlipidemia.
    Perry RS.
    Clin Pharm; 1986 Feb 01; 5(2):113-27. PubMed ID: 3514084
    [Abstract] [Full Text] [Related]

  • 8. Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
    Schulman KA, Kinosian B, Jacobson TA, Glick H, Willian MK, Koffer H, Eisenberg JM.
    JAMA; 1990 Dec 19; 264(23):3025-33. PubMed ID: 2123013
    [Abstract] [Full Text] [Related]

  • 9. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR, Bacon S.
    Arteriosclerosis; 1989 Dec 19; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [Abstract] [Full Text] [Related]

  • 10. Hyperlipidemia: reducing the chances of cardiovascular disease.
    Nash DT.
    Geriatrics; 1984 Jul 19; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
    [No Abstract] [Full Text] [Related]

  • 11. Choice of cholesterol-lowering drugs.
    Med Lett Drugs Ther; 1993 Mar 05; 35(891):19-22. PubMed ID: 8433674
    [No Abstract] [Full Text] [Related]

  • 12. [Advances in pharmacotherapy of arteriosclerosis].
    Balewska K, Witanowska A.
    Pol Tyg Lek; 1993 Mar 05; 45(6-7):103-7. PubMed ID: 2216947
    [No Abstract] [Full Text] [Related]

  • 13. Criteria for use of hypolipidemic agents in adults.
    Morales E, Spinler SA, Wilson MD, Chin MM, Jozefiak E.
    Am J Hosp Pharm; 1994 Nov 15; 51(22):2837-41. PubMed ID: 7856612
    [No Abstract] [Full Text] [Related]

  • 14. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1985 Aug 30; 27(695):74-6. PubMed ID: 3860714
    [No Abstract] [Full Text] [Related]

  • 15. The diagnosis and management of hyperlipidemia.
    Gotto AM, Jones PH, Scott LW.
    Dis Mon; 1986 May 30; 32(5):245-311. PubMed ID: 3519132
    [No Abstract] [Full Text] [Related]

  • 16. The effects of gemfibrozil on hyperlipidemia in children with persistent nephrotic syndrome.
    Büyükçelik M, Anarat A, Bayazit AK, Noyan A, Ozel A, Anarat R, Aydingülü H, Dikmen N.
    Turk J Pediatr; 2002 May 30; 44(1):40-4. PubMed ID: 11858378
    [Abstract] [Full Text] [Related]

  • 17. Gemfibrozil in combination with other drugs for severe hyperlipidemia. Preliminary study comprising four cases.
    Nash DT.
    Postgrad Med; 1983 Apr 30; 73(4):75-82. PubMed ID: 6572892
    [Abstract] [Full Text] [Related]

  • 18. [Effect of combined treatment with lovastatin and colestipol on serum lipids and lipoproteins].
    Kłosiewicz-Latoszek L, Nowicka G, Szostak WB.
    Wiad Lek; 1993 Aug 30; 46(15-16):581-5. PubMed ID: 7975581
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hyperlipidaemias. Current avenues and new horizons.
    Janus ED.
    Aust Fam Physician; 1989 Sep 30; 18(9):1071-4, 1078-83, 1086. PubMed ID: 2590074
    [Abstract] [Full Text] [Related]

  • 20. Management of the hyperlipidaemias.
    Drug Ther Bull; 1980 Mar 28; 18(7):25-8. PubMed ID: 7371502
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.